New search | Conferencedetail
mail
Print view
 
 

12th Tumor Models Boston

Evvnt Promotion / evvnt
-
23.07.2024 - 24.07.2024  The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, Massachusetts, USA
Time: 8:00 AM - 4:10 PM
 
Conference themes
In the wake of the FDA Modernization Act and translational rates of cancer drugs into the clinic at just 20%, it is critical that oncology scientists invest in more translational and predictive models to de-risk the validation of novel targets, predict therapeutic response, and support biomarker discovery.
Professional congress organizer (PCO)
Hanson Wade Group
Notes
Brochure: https://go.evvnt.com/2397551-3?pid=4832

Speakers: Alexander Adler, Principal Scientist and Research Associate, Regeneron Pharmaceuticals Inc, Alina Ainbinder, Principal Scientist, Takeda Pharmaceuticals Co. Ltd., and more
 

Enquiries and Registration:

https://go.evvnt.com/2397551-2?pid=4832
Mr. Alex Domingo
 
Categories
Oncology
Languages
English
Congress fees
Drug Developer, Researchers and Academic - 2 Day Conference Pass: USD 0.50, Solution Provider - 2 Day Conference Pass: USD 3699.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichische Gesellschaft für Public HealthAGEM - Arbeitsgemeinschaft Ethnologie und MedizinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Hilfswerk AustriaCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAlumni Club Medizinische Universität WienHelix - Forschung & Beratung WienCenter of Excellence